Hunan Oya Pharmaceutical

Hunan Oya Pharmaceutical is a China-based pharmaceutical company established in 2007, specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. The company operates two GMP-certified production sites and three R&D centers located in Suzhou, Wuhan, and Changsha. Its product portfolio spans several therapeutic areas, including oncology, cardiovascular, anti-viral, and gastrointestinal health, with a particular focus on triptans for migraine and intermediates for major cancer drugs like Olaparib and Enzalutamide. In addition to its own product line, Hunan Oya provides comprehensive CDMO services, supporting partners from process optimization to large-scale commercial production. The company is recognized as a High-tech Enterprise and a Little Giant Enterprise in Hunan Province, serving both domestic and international markets.